This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Loeb, H. S. Articles by Gunner, R. M. Search for Related Content PubMed PubMed Citation Articles by Loeb, H. S. Articles by Gunner, R. M.

Circulation, Vol 55, 375-378, Copyright © 1977 by American Heart Association

ARTICLES

Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure

HS Loeb, J Bredakis and RM Gunner

Dobutamine is a newly developed catecholamine reported to have minimal direct vascular effects relative to its inotropic activity and to have less chronotropic and arrhythmogenic properties than other catecholamines used in the treatment of low output states. In this study, the acute hemodynamic effects of dobutamine were compared to those of dopamine in 13 patients with chronic low output cardiac failure. At dosages adjusted to achieve similar increments in cardiac output, dobutamine reduced left ventricular filling pressure (LVEP) from 24 +/- 2 mm Hg (SEM) to 17+/- 2 mm Hg, while dopamine increased LVEP to 30 +/- 3 mm Hg and in six patients caused arterial O2 saturation to fall below 90%. This poor response to dopamine was probably the result of its vasoconstrictive effects and illustrates the potential advantages of using a cardioselective agent such as dobutamine when the desired goal of therapy is to improve ventricular function by direct inotropic stimulation.

This article has been cited by other articles:

				H. Sakai, H. Kunichika, K. Murata, K. Seki, K. Katayama, T. Hiro, T. Miura, and M. Matsuzaki Improvement of afterload mismatch of left atrial booster pump function with positive inotropic agent J. Am. Coll. Cardiol., January 1, 2001; 37(1): 270 - 277. [Abstract] [Full Text] [PDF]

				J. E. Naschitz, D. Yeshurun, and J. Shahar Cardiogenic Hepatorenal Syndrome Angiology, November 1, 1990; 41(11): 893 - 900. [Abstract] [PDF]

				C. V. LEIER and D. V. UNVERFERTH Drugs Five Years Later: Dobutamine Ann Intern Med, October 1, 1983; 99(4): 490 - 496. [Abstract] [PDF]